论文部分内容阅读
目的：研究碳酸锂治疗偏头痛的疗效，并与尼莫地平作比较。方法：将１２８例偏头痛病人随机分成２组，碳酸锂组６４例服用碳酸锂，每日剂量０．５～２．０ｇ，分２～３次饭后服用，１５ｄ后改为０．５ｇｑｄ，再服用１５ｄ。尼莫地平组６４例服用尼莫地平３０ｍｇ，ｔｉｄ，１５ｄ后改用３０ｍｇ，ｑｄ，连用１５ｄ。结果：近期治愈率碳酸锂组与尼莫地平组分别为５６％及３５％（Ｐ＜０．０５）。总有效率碳酸锂组与尼莫地平组分别为９５％及９２％（Ｐ＞０．０５）。结论：碳酸锂治疗偏头痛不仅有效，且有较高的近期治愈率。
Objective: To study the curative effect of lithium carbonate on migraine and to compare with nimodipine. Methods: 128 migraineurs were randomly divided into two groups. In lithium carbonate group, 64 patients took lithium carbonate and the daily dose was 0.5-2.0g. The migraine patients were divided into two or three meals and then changed to 0.5gqd after 15 days. Take another 15d. Nimodipine group of 64 patients taking nimodipine 30mg, tid, 15d after the switch to 30mg, qd, once every 15d. Results: The recent cure rates for lithium carbonate and nimodipine were 56% and 35%, respectively (P <0.05). The total effective rate of lithium carbonate group and nimodipine group were 95% and 92% (P> 0.05). Conclusion: Lithium carbonate is not only effective in the treatment of migraine, but also has a high rate of recent cure.